Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

MLA

Florentia Peintinger, et al. “Reproducibility of Residual Cancer Burden for Prognostic Assessment of Breast Cancer after Neoadjuvant Chemotherapy.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 28, no. 7, Dec. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d972ac47662c27618b0d92f5d2a762b7&authtype=sso&custid=ns315887.

APA

Florentia Peintinger, Christos Hatzis, Rebekah Gould, Constance Albarracin, Erinn Downs-Kelly, Bruno Valentin Sinn, Jerzy Morkowski, & W. Fraser Symmans. (2014). Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 28(7).

Chicago

Florentia Peintinger, Christos Hatzis, Rebekah Gould, Constance Albarracin, Erinn Downs-Kelly, Bruno Valentin Sinn, Jerzy Morkowski, and W. Fraser Symmans. 2014. “Reproducibility of Residual Cancer Burden for Prognostic Assessment of Breast Cancer after Neoadjuvant Chemotherapy.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 28 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d972ac47662c27618b0d92f5d2a762b7&authtype=sso&custid=ns315887.